In addition, recent data from Rosenson et al., show that Lp(a) activates monocytes to drive inflammation and thrombosis, suggesting that elevated Lp(a) may directly impact increasing immunothrombotic risk in patients with ASCVD [21]. This evidence concerns the gene LPA and atherosclerosis.